TGTGInsighttelegram intelligenceLIVE / telegram public index
← GitHub Trends

TGINSIGHT SIMILAR POSTS

Find similar content

Source channel @githubtrending · Post #15518 · Feb 24

#rust#ai#ai_ocr#attention_mechanism#gnn#gnn_model#gnns#graph#graph_neural_networks#llm_inference#low_latency#mincut#neo4j#ocr#onnx#rust#vector#wasm RuVector is a free, open-source vector database that gets smarter with every query. Unlike static databases, it learns from usage via GNN layers, runs LLMs locally with no cloud costs, supports graph queries like Neo4j, scales freely across nodes, and deploys as a single self-booting file (125ms startup). Run with `npx ruvector`. You benefit from faster, more accurate AI search that improves automatically, zero operating costs, full offline/privacy control, and easy scaling—perfect for RAG, agents, or edge apps without vendor lock-in. https://github.com/ruvnet/ruvector

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选
Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment